Dermatophytic Onychomycosis Treatment Market
- 2026 年市場規模
- USD 7,296.6 Mn
- 2033 年預估規模
- USD 12,219.7 Mn
- 年複合成長率 CAGR
- 7.6%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
完整報告名稱與涵蓋範圍
Dermatophytic Onychomycosis Treatment Market, By Product Type (Tablets(Rx, OTC)Mail Paints(Rx, OTC)), By Treatment (Oral, Topical), By End User (Hospitals, Clinics, Independent Pharmacies, Mail Order Pharmacies, Drug Stores), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East and Africa)
報告摘要
Nail onychomycosis is a fungal infection is caused by a trichophyton rubrum, trichophyton mentagrophytes, and in some cases it is caused by yeasts and molds. The major factors responsible for nail onchomycosis infection is increased exposure to worm and moist environment which leads to perfect condition for fungus to grow and proliferate. The major symptoms of onychomycosis comprises of white and yellow spots under the nail leading to discoloration, nail thickening, and formation of crumbling edges on the nail.
Key features of the study
• This report provides in-depth analysis of the global dermatophytic onychomycosis treatment market and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global dermatophytic onychomycosis treatment market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Valeant Pharmaceuticals International Inc., Galderma S.A., Novartis AG, Pfizer Inc., Moberg Pharma AB, Janssen Global Services, LLC (Johnson & Johnson Services, Inc.), Anacor Pharmaceuticals, Inc., NovaQuest Capital Management, L.L.C., and Novan, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The global dermatophytic onychomycosis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global dermatophytic onychomycosis treatment market
Market Segmentation
• By Product Type
o Tablets
o Nail Paints
• By Treatment
o Oral
o Topical
• By End User
o Hospitals
o Clinics
o Independent Pharmacies
o Mail Order Pharmacies
o Drug Stores
• By Region
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East & Africa
GCC Countries
Israel
Rest of Middle East & Africa
• Global Dermatophytic Onychomycosis Treatment Market: Competitive Landscape
o Valeant Pharmaceuticals International Inc.
o Galderma S.A.
o Novartis AG
o Pfizer Inc.
o Moberg Pharma AB
o Janssen Global Services, LLC (Johnson & Johnson Services, Inc.)
o Anacor Pharmaceuticals, Inc.
o NovaQuest Capital Management, L.L.C.
o Novan, Inc.
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Product Type
Market Snippet, By Treatment
Market Snippet, By End User
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Regulatory Scenario
o Reimbursement Scenario
o Merger and Acquisition Scenario
o PEST Analysis
4. Global Dermatophytic Onychomycosis Treatment Market, By Product Type, 2026 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2019 and 2033 (%)
Y-o-Y Growth Analysis, 2017 – 2033
Segment Trends
o Tablets
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Nail Paints
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
5. Global Dermatophytic Onychomycosis Treatment Market, By Treatment, 2026 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2019 and 2033 (%)
Y-o-Y Growth Analysis, 2017 – 2033
Segment Trends
o Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Topical
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
6. Global Dermatophytic Onychomycosis Treatment Market, By End User, 2026 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2019 and 2033 (%)
Y-o-Y Growth Analysis, 2017 – 2033
Segment Trends
o Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Independent Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Mail Order Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
o Drug Stores
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn)
7. Global Dermatophytic Onychomycosis Treatment Market, By Region, 2026 – 2033, (USD Mn)
o Introduction
Market Share Analysis, By Region, 2019 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2017–2033
o North America
Market Size and Forecast, By Product Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Treatment, 2026 – 2033, (USD Mn)
Market Size and Forecast, By End User, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o U.S.
o Canada
o Latin America
Market Size and Forecast, By Product Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Treatment, 2026 – 2033, (USD Mn)
Market Size and Forecast, By End User, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Market Size and Forecast, By Product Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Treatment, 2026 – 2033, (USD Mn)
Market Size and Forecast, By End User, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o Germany
o U.K.
o France
o Italy
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Size and Forecast, By Product Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Treatment, 2026 – 2033, (USD Mn)
Market Size and Forecast, By End User, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Market Size and Forecast, By Product Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Treatment, 2026 – 2033, (USD Mn)
Market Size and Forecast, By End User, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o GCC
o Israel
o Rest of Middle East
o Africa
Market Size and Forecast, By Product Type, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Treatment, 2026 – 2033, (USD Mn)
Market Size and Forecast, By End User, 2026 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2026 – 2033, (USD Mn)
o South Africa
o Central Africa
o North Africa
8. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
Valeant Pharmaceuticals International Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Galderma S.A.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Novartis AG
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Pfizer Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Moberg Pharma AB
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Janssen Global Services, LLC (Johnson & Johnson Services, Inc.)
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Anacor Pharmaceuticals, Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
NovaQuest Capital Management, L.L.C.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Novan, Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
o Analyst Views
9. Section
o References
o Research Methodology
o About Us and Sales Contact
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們